Skip to Content

Covalon Technologies Ltd CVALF Stock Quote

| Rating as of

PINX: CVALF

Market Closed

| Currency in USD

  • Last Close 1.01
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Growth
  • Day Range 1.01  –  1.01
  • Year Range 1.01  –  1.91
  • Market Cap 24.9779 Mil
  • Volume / Avg 774.0 /  3,005.8
  • Price / Sales 1.39
  • Price / Book 1.57
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis CVALF

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics CVALF

Company Profile CVALF

Business Description

Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.

Contact
1660 Tech Avenue, Unit 5
Mississauga, ON, L4W 5S7, CAN
Industry Biotechnology
Employees

Competitors & Peers CVALF

Morningstar does not cover competitors or peers for this firm.

FAQs for Covalon Technologies Ltd Stock

No. CVALF does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

CVALF’s market cap is 24.98 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

CVALF’s stock style is Small Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

CVALF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare CVALF’s historical performance against its industry peers and the overall market.